Verapamil + Lemborexant Interaction
Contraindicatedinteraction on record
Description
Moderate CYP3A inhibitor that increases lemborexant AUC and Cmax, increasing risk of adverse reactions. Concomitant use should be avoided.
Mechanism
CYP3A inhibition
Source: NLP:lemborexant